Ovid therapeutics (OVID) Financials

Ovid Therapeutics Inc. (OVID) is a biopharmaceutical company focused on developing novel medicines to transform the lives of patients with rare neurological disorders. As part of their commitment to transparency and accountability, Ovid regularly releases their financial statements which provide insights into the company's performance and financial health. The income statement outlines the company's revenues, expenses, and net income over a specific period. It helps investors and stakeholders understand Ovid's profitability and growth potential. Ovid's EBIT (Earnings Before Interest and Taxes) is a measure of profitability that indicates the company's operating performance without considering the impact of interest and taxes. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) provides a clearer picture of Ovid's operating profitability by excluding non-cash expenses like depreciation and amortization. Gross profit represents the difference between Ovid's total revenue and the cost of goods sold. It reflects the profitability of the company's core business operations. Net income from stockholders is the profit left for shareholders after deducting all expenses, taxes, and interest payments. Total revenue is the sum of all revenue generated by Ovid from the sale of its products or services. It is a key indicator of the company's overall financial performance. The balance sheet provides a snapshot of Ovid's financial position at a specific point in time. It lists the company's assets, liabilities, and stockholders' equity. Cash equivalents refer to highly liquid assets that can be easily converted into cash. They include cash on hand and short-term investments. Net debt is calculated by subtracting a company's cash and cash equivalents from its total debt. It helps assess Ovid's ability to meet its debt obligations. Stockholders' equity represents the residual interest in the assets of the company after deducting liabilities. It reflects the shareholders' stake in Ovid's assets. Total assets include all the resources owned by Ovid, including cash, inventory, property, and investments. Total debt refers to the outstanding amount of money that Ovid owes to lenders or creditors. It includes both short-term and long-term debt obligations. Total liabilities represent Ovid's financial obligations and debts. They include both short-term and long-term liabilities. Cash flow refers to the movement of money in and out of Ovid's business. It provides insights into the company's ability to generate cash and manage its operating, investing, and financing activities. Financing cash flow represents the cash flows related to Ovid's financing activities, such as issuing or repurchasing shares, and borrowing or repaying debt. Free cash flow is the cash flow available to Ovid after deducting capital expenditures. It indicates the company's ability to generate excess cash that can be used for growth, acquisitions, or returning value to shareholders. Investing cash flow reflects the cash flows related to Ovid's investments in property, plant, and equipment, as well as acquisitions and sales of long-term assets. Operating cash flow represents the cash flows generated from Ovid's core business operations. It indicates the company's ability to generate cash from its day-to-day activities.